Naltrexone/Bupropion ER (Contrave): Newly Approved Treatment Option for Chronic Weight Management in Obese Adults.

Matthew M Sherman, Sinziana Ungureanu, Jose A Rey

PubMed · 2016 · 77 citations · 14 references

Concepts

Abstract

Naltrexone/bupropion ER (Contrave): newly approved treatment option for chronic weight management in obese adults.

References

14